EQS-Adhoc: MEDIQON Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on December 12, 2022
|
EQS-Ad-hoc: MEDIQON Group AG / Key word(s): Capital Increase
MEDIQON Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on December 12, 2022
13-Dec-2022 / 08:34 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The private placement of the capital increase resolved on December 12, 2022, excluding subscription rights by issuing new shares was successfully completed in the amount of 1,067,267 new shares. The increase is equivalent to c. 7.1% of the company’s existing share capital. The subscription price was EUR 14.50 per new share, resulting in gross proceeds of c. EUR 15.5m.
Subject to the registration in the Commercial Register, the share capital increases from EUR 14,999,333.00 to EUR 16,066,600.00.
13-Dec-2022 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
|
| Language: |
English |
| Company: |
MEDIQON Group AG |
|
Herzog-Adolph-Strasse 2 |
|
61462 Königstein im Taunus |
|
Germany |
| Phone: |
+49 (0) 6174-9687040 |
| Fax: |
+49 (0) 6174-9687043 |
| E-mail: |
[email protected] |
| Internet: |
www.mediqon-group.de |
| ISIN: |
DE0006618309, DE000A254TL0 |
| WKN: |
661830, A254TL |
| Listed: |
Regulated Unofficial Market in Berlin, Frankfurt (Basic Board), Stuttgart |
| EQS News ID: |
1511161 |
| |
| End of Announcement |
EQS News Service |
1511161 13-Dec-2022 CET/CEST
|
Die wichtigsten Finanzdaten auf einen Blick
|
| |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023e |
| Umsatzerlöse1 |
3,21 |
2,64 |
0,10 |
1,08 |
28,66 |
42,07 |
0,00 |
| EBITDA1,2 |
0,72 |
8,99 |
-0,44 |
-0,61 |
6,21 |
10,50 |
0,00 |
| EBITDA-Marge3 |
22,43 |
340,53 |
-440,00 |
-56,48 |
21,67 |
24,96 |
|
| EBIT1,4 |
0,51 |
8,65 |
-5,51 |
-2,56 |
0,94 |
2,51 |
0,00 |
| EBIT-Marge5 |
15,89 |
327,65 |
-5.510,00 |
-237,04 |
3,28 |
5,97 |
0,00 |
| Jahresüberschuss1 |
0,54 |
7,51 |
-5,01 |
-2,27 |
-2,27 |
-6,60 |
0,00 |
| Netto-Marge6 |
16,82 |
284,47 |
-5.010,00 |
-210,19 |
-7,92 |
-15,69 |
0,00 |
| Cashflow1,7 |
0,75 |
7,85 |
-5,00 |
-1,13 |
2,87 |
5,69 |
0,00 |
| Ergebnis je Aktie8 |
0,24 |
3,04 |
-1,50 |
-0,18 |
0,38 |
0,05 |
0,23 |
| Dividende8 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2022 - Kostenfrei herunterladen. 
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: BDO
|
| INVESTOR-INFORMATIONEN |
| ©boersengefluester.de |
| Chapters Group |
| WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
| 661830 |
22,200 |
Kaufen |
366,28 |
| KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
| 44,40 |
17,40 |
2,64 |
70,48 |
| KBV |
KCV |
KUV |
EV/EBITDA |
| 3,76 |
64,34 |
8,71 |
38,30 |
| Dividende '22 in € |
Dividende '23e in € |
Div.-Rendite '23e
in % |
Hauptversammlung |
| 0,00 |
0,00 |
0,00 |
09.07.2024 |
| Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
|
29.09.2023 |
|
24.05.2024 |
| Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
| 11,02% |
34,93% |
21,31% |
50,00% |
|
|
MEDIQON Group AG DE0006618309